Search
  • Search


Ireland: Tenders/Children's Health Ireland (CHI)/Future testing for The National Newborn Bloodspot Screening Laboratory (NNBSL) in Children's Health Ireland (CHI).
  1. Planning notice published

    Sep 25, 2024 1:33 PMSeptember 25, 2024 1:33 PM
  2. Planned competition start

    Feb 14, 2025 12:00 AMFebruary 14, 2025 12:00 AM

Brief

Future testing for The National Newborn Bloodspot Screening Laboratory (NNBSL) in Children's Health Ireland (CHI).

Planned

The competition has not been announced yet.

Deadline
Jan 25, 2025Expired
Agreement
Buying services
Estimated value
€1

Brief

Children’s Health Ireland (CHI) is reviewing the scope of future testing for The National Newborn Bloodspot Screening Laboratory (NNBSL). The NNBSL in CHI is the only laboratory in the Republic of Ireland providing a newborn bloodspot screening service. The future testing being reviewed is for a combined molecular screening of two disorders: Severe Combined Immunodeficiency (SCID) and Spinal Muscular Atrophy (SMA). The current expectation is that any proposal will need to cover the full equipment solution (analysers, reagents, consumables, auxiliary equipment) for SMA and SCID testing from sample receipt to result. The detailed scope will be issued with any potential formal procurement that may be initiated, but as a minimum will include the provision of testing for SMA and SCID. The aim of this notice is: 1. Notify the market of the intention of CHI to start a formal procurement process for the appointment of a testing provider for SMA and SCID; 2. Ensure any interested parties have enough time to prepare for and be ready for a procurement; and 3. Allow the Contracting Authority to receive feedback on market expertise on SMA and SCID testing. It is important to note that this notification is not a call for competition and as such you will need to express your interest in any future tender opportunity if a contract notice is published in OJEU. It should also be noted that this notification invites organisations to express an interest in this PIN only, and it is not a pre-qualification questionnaire or selection questionnaire, and is not part of any pre-qualification or selection process. This notice is intended as an awareness, communication, and information gathering exercise. This notice is no indication of a commitment to participate in any process nor does it infer any preferential or special status on those individuals and organisations who express an interest. Please note that any interested party is to simply register their expression of interest in this PIN by sending a message through this e-tendering system and your interest will be noted. The Contracting Authority will contact any interested parties following receipt of registration. To register your interest for this potential opportunity, please respond with the following information: • Name of the company • Name of key representative • Contact details of key representative if you wish for the Contracting Authority to contact you to discuss the details of the future SMA SCID testing at CHI

Laboratorietjenester

Custom Assessment Criteria

  • Get answers to your bid/no-bid criteria

    Set them up once and Cobrief answers them in every tender

Will you bid?

The agent sets up the bid and writes the first draft. Free for 14 days.

Previous winners

  • Who are you up against?

    The suppliers who have won similar contracts at Children's Health Ireland (CHI)

From the notice

  • Children’s Health Ireland (CHI) is reviewing the scope of future testing for The National Newborn Bloodspot Screening Laboratory (NNBSL). The NNBSL in CHI is the only laboratory in the Republic of Ireland providing a newborn bloodspot screening service. The future testing being reviewed is for a combined molecular screening of two disorders: Severe Combined Immunodeficiency (SCID) and Spinal Muscular Atrophy (SMA). The current expectation is that any proposal will need to cover the full equipment solution (analysers, reagents, consumables, auxiliary equipment) for SMA and SCID testing from sample receipt to result. The detailed scope will be issued with any potential formal procurement that may be initiated, but as a minimum will include the provision of testing for SMA and SCID. The aim of this notice is: 1. Notify the market of the intention of CHI to start a formal procurement process for the appointment of a testing provider for SMA and SCID; 2. Ensure any interested parties have enough time to prepare for and be ready for a procurement; and 3. Allow the Contracting Authority to receive feedback on market expertise on SMA and SCID testing. It is important to note that this notification is not a call for competition and as such you will need to express your interest in any future tender opportunity if a contract notice is published in OJEU. It should also be noted that this notification invites organisations to express an interest in this PIN only, and it is not a pre-qualification questionnaire or selection questionnaire, and is not part of any pre-qualification or selection process. This notice is intended as an awareness, communication, and information gathering exercise. This notice is no indication of a commitment to participate in any process nor does it infer any preferential or special status on those individuals and organisations who express an interest. Please note that any interested party is to simply register their expression of interest in this PIN by sending a message through this e-tendering system and your interest will be noted. The Contracting Authority will contact any interested parties following receipt of registration. To register your interest for this potential opportunity, please respond with the following information: • Name of the company • Name of key representative • Contact details of key representative if you wish for the Contracting Authority to contact you to discuss the details of the future SMA SCID testing at CHI

  • Contact

    robert.keogh@olhsc.ie
  • Type
    Planning
  • Main code
    Laboratory services
    71900000
  • 33100000Medical equipments

Similar active competitions

  • Children's Health Ireland (CHI)

    Engroshandel med medisinske og husholdningsvarer

    Design and Supply of Newborn Screening Cards for the Collection of Blood Samples for the National Newborn Screening Programme

    Children’s Health Ireland (CHI) needs the design and supply of newborn screening cards for the National Newborn Screening Programme under a 5-year supply contract, with a stated maximum total value of €1. The cards must use suitable filter paper to collect heel-prick blood samples from infants, accommodate metabolites currently analysed and future additions, and provide space for full infant demographics and other programme-required details. Delivery is in Dublin.

    Competition
    Dec 10, 2026(21 days)
    €1
  • St James's Hospital

    Laboratorie- og analyseutstyr

    Invitation to tender for the provision of Lymphoma Clonality Testing Reagents and Associated Controls for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

    St James's Hospital needs Lymphoma Clonality Testing Reagents and Associated Controls for the Cancer Molecular Diagnostics Department in Dublin for a maximum total value of 375,000 EUR over 60 months. The reagents and consumables are required to continue providing legacy clonality testing using capillary electrophoresis, while the laboratory develops Next Generation Sequencing (NGS) based testing methodologies.

    Competition
    Nov 19, 2026(0 days)
    €375,000
  • St James's Hospital

    Laboratorie-, optisk- og presisjonsutstyr

    Invitation to Tender for the Provision of an Immunoassay and Allergy Analytical Platform for the St James’s Hospital Immunology Laboratory.

    St James’s Hospital needs an immunoassay and allergy analytical platform for its Immunology Laboratory under a 5-year contract, with a maximum total value of €9.625 million. The supply will support automated testing of a broad range of autoantibodies and allergens used to investigate autoimmune and allergic diseases and inform diagnosis, monitoring and treatment for adult and paediatric patients. Delivery is for the hospital’s laboratory in Dublin.

    Competition
    Dec 10, 2026(21 days)
    €9,625,000